No photo of Minna Oksanen

Minna Oksanen

  • PL 21 (Haartmaninkatu 3)

    00014

    Finland

20102018

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

Filter
Article
2018

Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy

Hemminki, O., Oksanen, M., Taipale, K., Liikanen, I., Koski, A., Joensuu, T., Kanerva, A. & Hemminki, A., 29 Jun 2018, In : Molecular Therapy - Oncolytics. 9, p. 41-50 10 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File
2016

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

Taipale, K., Liikanen, I., Juhila, J., Turkki, R., Tahtinen, S., Kankainen, M., Vassilev, L., Ristimaki, A., Koski, A., Kanerva, A., Diaconu, I., Cerullo, V., Vaha-Koskela, M., Oksanen, M., Linder, N., Joensuu, T., Lundin, J. & Hemminki, A., Jan 2016, In : Molecular therapy. 24, 1, p. 175-183 9 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access

Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer

Liikanen, I., Tähtinen, S., Guse, K., Gutmann, T., Savola, P., Oksanen, M., Kanerva, A. & Hemminki, A., 1 Sep 2016, In : Molecular Cancer Therapeutics. 15, 9, p. 2259-2269 11 p.

Research output: Contribution to journalArticleScientificpeer-review

Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer

Bramante, S., Koski, A., Liikanen, I., Vassilev, L., Oksanen, M., Siurala, M., Heiskanen, R., Hakonen, T., Joensuu, T., Kanerva, A., Pesonen, S. & Hemminki, A., 2016, In : OncoImmunology. 5, 2, 8 p., 1078057.

Research output: Contribution to journalArticleScientificpeer-review

Open Access

Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy

Taipale, K., Liikanen, I., Koski, A., Heiskanen, R., Kanerva, A., Hemminki, O., Oksanen, M., Gronberg-Vaha-Koskela, S., Hemminki, K., Joensuu, T. & Hemminki, A., Jul 2016, In : Molecular therapy. 24, 7, p. 1323-1332 10 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
2015

Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues

Koski, A., Bramante, S., Kipar, A., Oksanen, M., Juhila, J., Vassilev, L., Joensuu, T., Kanerva, A. & Hemminki, A., Oct 2015, In : Molecular therapy. 23, 10, p. 1641-1652 12 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Case-Control Estimation of the Impact of Oncolytic Adenovirus on the Survival of Patients With Refractory Solid Tumors

Kanerva, A., Koski, A., Liikanen, I., Oksanen, M., Joensuu, T., Hemminki, O., Palmgren, J., Hemminki, K. & Hemminki, A., Feb 2015, In : Molecular therapy. 23, 2, p. 321-329 9 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Immunological data from cancer patients treated with Ad5/3-E2F-Delta 24-GMCSF suggests utility for tumor immunotherapy

Hemminki, O., Parviainen, S., Juhila, J., Turkki, R., Linder, N., Lundin, J., Kankainen, M., Ristimaki, A., Koski, A., Liikanen, I., Oksanen, M., Nettelbeck, D. M., Kairemo, K., Partanen, K., Joensuu, T., Kanerva, A. & Hemminki, A., 28 Feb 2015, In : Oncotarget. 6, 6, p. 4467-4481 15 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy

Liikanen, I., Koski, A., Merisalo-Soikkeli, M., Hemminki, O., Oksanen, M., Kairemo, K., Joensuu, T., Kanerva, A. & Hemminki, A., Mar 2015, In : OncoImmunology. 4, 3, 13 p.

Research output: Contribution to journalArticleScientific

Open Access

T-cell Subsets in Peripheral Blood and Tumors of Patients Treated With Oncolytic Adenoviruses

Taipale, K., Liikanen, I., Juuso, J., Aila, K-K., Oksanen, M., Turkki, R., Linder, N., Lundin, J., Ristimäki, A., Kanerva, A., Koski, A., Joensuu, T., Vähä-Koskela, M. & Hemminki, A., May 2015, In : Molecular therapy. 23, 5, p. 964-973 10 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

Bramante, S., Kaufmann, J. K., Veckman, V., Liikanen, I., Nettelbeck, D. M., Hemminki, O., Vassilev, L., Cerullo, V., Oksanen, M., Heiskanen, R., Joensuu, T., Kanerva, A., Pesonen, S., Matikainen, S., Vaha-Koskela, M., Koski, A. & Hemminki, A., 1 Oct 2015, In : International Journal of Cancer. 137, 7, p. 1775-1783 9 p.

Research output: Contribution to journalArticleScientificpeer-review

2014

Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans

Bramante, S., Koski, A., Kipar, A., Diaconu, I., Liikanen, I., Hemminki, O., Vassilev, L., Parviainen, S., Cerullo, V., Pesonen, S. K., Oksanen, M., Heiskanen, R., Rouvinen-Lagerstroem, N., Merisalo-Soikkeli, M., Hakonen, T., Joensuu, T., Kanerva, A-M., Pesonen, S. & Hemminki, A., 1 Aug 2014, In : International Journal of Cancer. 135, 3, p. 720-730 11 p.

Research output: Contribution to journalArticleScientificpeer-review

2013

[F-18]-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography in Response Evaluation of Oncolytic Adenovirus Treatments of Patients with Advanced Cancer

Koski, A., Ahtinen, H., Liljenback, H., Roivainen, A., Koskela, A., Oksanen, M., Partanen, K., Laasonen, L., Kairemo, K., Joensuu, T. & Hemminki, A., 1 Dec 2013, In : Human Gene Therapy. 24, 12, p. 1029-1041 13 p.

Research output: Contribution to journalArticleScientificpeer-review

Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus

Kanerva, A., Nokisalmi, P., Diaconu, I., Koski, A., Cerullo, V., Liikanen, I., Tahtinen, S., Oksanen, M., Heiskanen, R., Pesonen, S., Joensuu, T., Alanko, T., Partanen, K., Laasonen, L., Kairemo, K., Pesonen, S., Kangasniemi, L. & Hemminki, A., 15 May 2013, In : Clinical Cancer Research. 19, 10, p. 2734-2744 11 p.

Research output: Contribution to journalArticleScientificpeer-review

Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment

Hirvinen, M., Heiskanen, R., Oksanen, M., Pesonen, S., Liikanen, I., Joensuu, T., Kanerva, A., Cerullo, V. & Hemminki, A., 21 Aug 2013, In : Journal of Translational Medicine. 11, Article Number: 193, 12 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients

Liikanen, I., Ahtiainen, L., Hirvinen, M. L. M., Bramante, S., Cerullo, V., Nokisalmi, P., Hemminki, O., Diaconu, I., Pesonen, S., Koski, A., Kangasniemi, L., Pesonen, S. K., Oksanen, M., Laasonen, L., Partanen, K., Joensuu, T., Zhao, F., Kanerva, A. & Hemminki, A., Jun 2013, In : Molecular therapy. 21, 6, p. 1212-1223 12 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Oncolytic Virotherapy Trials-Letter

Hemminki, A., Oksanen, M. & Merisalo-Soikkeli, M., 15 Aug 2013, In : Clinical Cancer Research. 19, 16, p. 4541-4542 2 p.

Research output: Contribution to journalArticleScientific

2012

Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors.

Pesonen, S., Diaconu, I., Cerullo, V., Escutenaire, S., Raki, M., Kangasniemi, L., Nokisalmi, P., Dotti, G., Guse, K., Laasonen, L., Partanen, K., Karli, E., Haavisto, E., Oksanen, M. K., Karioja-Kallio, A., Hannuksela, P., Sirkka-Liisa, H., Kauppinen, S., Joensuu, T. K., Kanerva, A. & 1 others, Hemminki, A. E., 2012, In : International Journal of Cancer. 130, 8, p. 1937-1947 11 p.

Research output: Contribution to journalArticleScientificpeer-review

Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients

Pesonen, S., Diaconu, I., Kangasniemi, L., Ranki, T., Kanerva, A-M., Pesonen, S. K., Gerdemann, U., Leen, A. M., Kairemo, K., Oksanen, M., Haavisto, E., Sirkka-Liisa, H., Karioja-Kallio, A., Kauppinen, S., Partanen, K. P. L., Laasonen, L., Joensuu, T., Alanko, T., Cerullo, V. & Hemminki, A., 2012, In : Cancer Research. 72, 7, p. 1621-1631 11 p.

Research output: Contribution to journalArticleScientificpeer-review

2011

Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus

Cerullo, V., Diaconu, I., Kangasniemi, L., Rajecki, M., Escutenaire, S., Koski, A., Romano, V., Rouvinen, N., Tuuminen, T., Laasonen, L., Partanen, K., Kauppinen, S., Joensuu, T., Oksanen, M., Holm, S-L., Haavisto, E., Karioja-Kallio, A., Kanerva, A., Pesonen, S., Arstila, P. T. & 1 others, Hemminki, A., 2011, In : Molecular therapy. 19, 9, p. 1737-1746 10 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access

In vivo and in vitro distribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments

Escutenaire, S., Cerullo, V., Diaconu, I., Ahtiainen, L., Hannuksela, P., Oksanen, M., Haavisto, E., Karioja-Kallio, A., Holm, S-L., Kangasniemi, L., Ribacka, C., Kauppinen, S., Joensuu, T. K., Arstila, T. P., Pesonen, S., Kanerva, A. & Hemminki, A., 2011, In : Annals of Medicine. 43, 2, p. 151-163 13 p.

Research output: Contribution to journalArticleScientificpeer-review

Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients

Raki, M., Särkioja, M. A., Escutenaire, S., Kangasniemi, L., Haavisto, E., Kanerva, A-M., Cerullo, V., Joensuu, T., Oksanen, M. K., Pesonen, S. & Hemminki, A. E., 2011, In : Journal of Gene Medicine. 13, 5, p. 253-261 9 p.

Research output: Contribution to journalArticleScientificpeer-review

2010

Oncolytic Adenovirus ICOVIR-7 in Patients with Advanced and Refractory Solid Tumors

Nokisalmi, P., Pesonen, S., Escutenaire, S., Sarkioja, M., Raki, M., Cerullo, V., Laasonen, L., Alemany, R., Rojas, J., Cascallo, M., Guse, K., Rajecki, M., Kangasniemi, L., Haavisto, E., Karioja-Kallio, A., Hannuksela, P., Oksanen, M. K., Kanerva, A., Joensuu, T., Ahtiainen, L. & 1 others, Hemminki, A., 2010, In : Clinical Cancer Research. 16, p. 3035-3043 9 p.

Research output: Contribution to journalArticleScientificpeer-review

Oncolytic adenovirus treatment of a patient with refractory neuroblastoma

Pesonen, S., Helin, H., Nokisalmi, P., Escutenaire, S., Ribacka, C., Särkioja, M., Cerullo, V., Guse, K., Bauerschmitz, G., Laasonen, L., Kantola, T., Ristimäki, A., Rajecki, M., Oksanen, M., Haavisto, E., Kanerva, A., Joensuu, T. & Hemminki, A., 2010, In : Acta Oncologica. 49, p. 117-119 3 p.

Research output: Contribution to journalArticleScientific

Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors

Pesonen, S., Nokisalmi, P., Escutenaire, S., Sarkioja, M., Raki, M., Cerullo, V., Kangasniemi, L., Laasonen, L., Ribacka, C., Guse, K., Haavisto, E., Oksanen, M. K., Rajecki, M., Helminen, A., Ristimaki, A., Karioja-Kallio, A., Karli, E., Kantola, T., Bauerschmitz, G., Kanerva, A. & 2 others, Joensuu, T. & Hemminki, A., 2010, In : Gene Therapy (Basingstoke). 17, 7, p. 892-904 13 p.

Research output: Contribution to journalArticleScientificpeer-review

Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF

Koski, A., Kangasniemi, L., Escutenaire, S., Pesonen, S., Cerullo, V., Diaconu, I., Nokisalmi, P., Raki, M., Rajecki, M., Guse, K., Ranki, T., Oksanen, M. K., Holm, S-L., Haavisto, E., Karioja-Kallio, A., Laasonen, L., Partanen, K., Ugolini, M., Helminen, A., Karli, E. & 5 others, Hannuksela, P., Pesonen, S., Joensuu, T., Kanerva, A. & Hemminki, A., 2010, In : Molecular therapy. 18, 10, p. 1874-1884 11 p.

Research output: Contribution to journalArticleScientificpeer-review

Ulkomaiset lääkärit, hammaslääkärit ja tieteelliset jatko-opiskelijat Suomessa

Myllykangas, L. T., Paunio, T., Lundin, J. E., Marjamaa, A., Silander, K., Pennanen, P., Aarnio, M., Oksanen, M. K., Dias, J., Pesonen, S. & Hemminki, A. E., 2010, In : Suomen lääkärilehti. 41, p. 3309-3314

Research output: Contribution to journalArticleProfessional